The success of a pragmatic trial hinges on the active involvement and cooperation of various partners. This section explores the unique contributions of key partners, including but not limited to, patients and the public, caregivers, advocacy groups, clinicians, health delivery organization leaders, operational personnel, policy makers and regulators, research funders, manufacturers, and medical societies. By recognizing the roles and perspectives of these diverse partners, you will understand how their collective efforts drive the success and impact of pragmatic trials.

Modules from this section, featured in previous weeks, will be posted here over time.